Janet Yakubu Nale

Twenty-three per-reviewed publications (26 publications), H-index of 13, Associate Fellow of the HEA (2016), PhD (2013) and MRes (2009). Over two decades research hands-on experience in Microbiology with eighteen years focus on pre-clinical development of therapeutic phage (virus of bacteria) formulations as alternative therapeutics, and as adjuncts to antibiotics. Expertise in many systems but a particular skill set in phage development for the treatment of human nosocomial pathogens and bacterial zoonoses. Pioneered several pre-clinical studies on therapeutic phage development for Clostridioides difficile, Salmonella enterica, Pseudomonas aeruginosa and Escherichia coli. Developing biofilm, cell culture, artificial human gut and Galleria mellonella model systems to test safety, efficacy and specificity of phages in the targeted eradication of bacterial infections. Phenotypic and genetic characterisation of bacterial pathogens. Role of prophages in bacterial diversity and pathogenicity. NHS Ethics. Successful supervision/co-supervised over 20 BSc, MSc and PhD phage research projects. Multiple AMI international travel grants and Microbiology Society President awards. Named researcher in many successful MRC, New Investigator, BBSRC, Gates Foundation, UK Government, industry (AmpliPhi, Enbiotix) and African Union research grants. Co-PI AHDB pork (£30,000). Delivering three Scottish Government projects at SRUC (~£2m).

2023: Scottish Qualifications Authority (SQA) NextGen-HN (course units writing/development)

2022/23SRUC Orcid commercialisation course

2022/23: SRUC Supervisors Skills course

2022: SRUC Research Intergrity course

2018: Non-Clinical Trail of an Investigational Medicinal Product (Good Clinical Practice) training University of Leicester, UK

2017 Scottish Accreditation Board (Home Office Licence) PILA, B and C (Mouse) certificate(Certificate number BE3071)

2015-2016 Associate Fellow of HEA, University of Leicester, UK. Postgraduate Certificate in Academic and Professional Practice aligned to the UK Professional Standard Framework

Diversity of Shiga toxin-producing E. coli (STEC) strains in Scottish ruminants

Phage in packaging for STEC O157

Phage genes as molecular tools for early detection of STEC O157

Phage therapy for bovine mastitis

Combined phage/probiotics therapeutics for postweaning diarrhoea in swine and poultry

Salmonella prophages

Salmonella Blackisle including small colony variants

Vaccine targets and phage therapy in aquaculture

Marine mammals Wildlife Biology and Health

Role of prophages in diversity, pathogenicity and control of zoonotic bacteria

Vaccine targets and phage therapy for Streptococcus agalactiae and Aeromonas spp in aquaculture

Phage complementation with probiotics to improve therapeutic efficacy to control post-weaning diarrhoea in pigs and colibacillosis infection in chickens.

1. Full member- Society for Applied Microbiology 2009-date

2. Full concessionary member UK and Ireland 2009-date

3. Member of the Genetics Society-April 2019-date

1. Reviewer for over 15 journals since 2016, with ~100 reviewing roles:

2. Editorial Board member: PHAGE: Therapy, Applications, and Research

3. Guest Associate Editorial roles: Frontiers in Microbiology- (The Role of Bacteriophages in Salmonella Diversity, Pathogenicity and Control), MDPI Pathogens- The Interactions Between Phages and Their Hosts, MDPI Antibiotics- (Combating Antimicrobial Resistance Spread in Food and Drinks Using Bacteriophage Technologies), PHAGE (Addressing Global Antimicrobial Resistance Through Africa Phage)